News Data keeps Lilly in race for new migraine treatment Company still in race to develop CGRP inhibitor for migraine.
Events Partner Content Data Integrity for Clinical Research Summit Data Integrity for Clinical Research Summit
News Valeant's Siliq price undercuts rivals to offset black box w... Siliq will be cheaper than rivals from Novartis and Eli Lilly.
News NHS proposes crackdown on erectile dysfunction drugs and sun... Eli Lilly's Cialis named on list of drugs no longer consider cost-effective.
News Novartis cues up Cosentyx as disease-modifying treatment for... Pharma begins early intervention trial after Cosentyx shows "disease modifying" properties
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
